FDA approves drug to treat advanced lung cancer

The Food and Drug Administration said Friday it approved a new drug from Boehringer Ingelheim for patients with a genetic variant of advanced lung cancer.

The agency said it approved the company's Gilotrif for lung cancer patients that test positive for certain gene mutations in their tumors. The agency approved the drug alongside a diagnostic test from Qiagen NV designed to detect the mutation. The test detects epidermal growth factor receptor abnormalities found in roughly 10 percent of patients with the most prevalent form of lung cancer, known as non-small cell lung cancer.

Lung cancer is the deadliest form of cancer among men and women in the U.S. and is expected to kill nearly 160,000 people this year, according to the National Cancer Institute.

For Subscribers

FOR SUBSCRIBERSRussia’s secrecy after a mysterious plague lab death raises global alarm

FOR SUBSCRIBERSAfter surviving a botched lethal injection, Christa Pike faces unprecedented legal battle

FOR SUBSCRIBERSHunger in a land of plenty: Major food banks face ‘heartbreaking’ need, NBC News survey finds

FOR SUBSCRIBERSInflation and tariffs push U.S. holiday spending projections to a record $1.7 trillion

FOR SUBSCRIBERSWhat happened inside the room where officials tried to execute Christa Pike by lethal injection

FOR SUBSCRIBERSHow we reported the saga of the CIA officer and his gold-bar stash

FOR SUBSCRIBERSBrad Raffensperger gears up to oversee his final election in Georgia

FOR SUBSCRIBERSDiddy is punished following NBC News report on his VIP life in prison and contraband cellphone use

FOR SUBSCRIBERS‘Too young to vote, old enough to be tear gassed’: French protesters’ anger swells

FOR SUBSCRIBERSDOJ gets aggressive in suing states that challenge Trump’s immigration policies

FOR SUBSCRIBERSJustice Department seeks criminal charge for former Trump aide Cassidy Hutchinson

FOR SUBSCRIBERS‘I just want to hold him’: USS Lincoln sailor to meet his 10-month-old son as ship docks

FOR SUBSCRIBERSSenate candidates run on raising Social Security taxes for higher incomes to prevent benefit cuts

FOR SUBSCRIBERSRussian operation that used ChatGPT tricked schools, a politician and media, OpenAI says

FOR SUBSCRIBERSTrump administration’s deal with Nevada fuels data center fight in governor’s race

Slide 1 of 1

The FDA specifically approved the drug for untreated cancer that has spread from the lungs.

For Subscribers

FOR SUBSCRIBERSRussia’s secrecy after a mysterious plague lab death raises global alarm

FOR SUBSCRIBERSAfter surviving a botched lethal injection, Christa Pike faces unprecedented legal battle

FOR SUBSCRIBERSHunger in a land of plenty: Major food banks face ‘heartbreaking’ need, NBC News survey finds

FOR SUBSCRIBERSInflation and tariffs push U.S. holiday spending projections to a record $1.7 trillion

FOR SUBSCRIBERSWhat happened inside the room where officials tried to execute Christa Pike by lethal injection

FOR SUBSCRIBERSHow we reported the saga of the CIA officer and his gold-bar stash

FOR SUBSCRIBERSBrad Raffensperger gears up to oversee his final election in Georgia

FOR SUBSCRIBERSDiddy is punished following NBC News report on his VIP life in prison and contraband cellphone use

FOR SUBSCRIBERS‘Too young to vote, old enough to be tear gassed’: French protesters’ anger swells

FOR SUBSCRIBERSDOJ gets aggressive in suing states that challenge Trump’s immigration policies

FOR SUBSCRIBERSJustice Department seeks criminal charge for former Trump aide Cassidy Hutchinson

FOR SUBSCRIBERS‘I just want to hold him’: USS Lincoln sailor to meet his 10-month-old son as ship docks

FOR SUBSCRIBERSSenate candidates run on raising Social Security taxes for higher incomes to prevent benefit cuts

FOR SUBSCRIBERSRussian operation that used ChatGPT tricked schools, a politician and media, OpenAI says

FOR SUBSCRIBERSTrump administration’s deal with Nevada fuels data center fight in governor’s race

Slide 1 of 1

"The approval of companion diagnostic tests and drugs are important developments in oncology, as they help us bring safe and effective treatments to patients who need them," said Alberto Gutierrez, FDA's director of in vitro diagnostics.

Shares of Netherlands-based Qiagen NV rose 73 cents, or 3.8 percent, to $20.68 in trading. Boehringer Ingelheim is based in Germany.